Amesh Adalja, MD

Amesh A. Adalja, MD, FACP, FACEP, FIDSA, “Post-COVID-19 Syndrome,” is senior scholar and adjunct assistant professor at Bloomberg School of Public Health, Center for Health Security at Johns Hopkins University in Baltimore, Maryland, a critical care physician at the US Department of Veterans Affairs, VA Pittsburgh Health System in Pittsburgh, Pennsylvania and adjunct assistant professor at the University of Pittsburgh Graduate School of Public Health and the School of Rehabilitation and Health Sciences. He is also an adjunct assistant professor at Carnegie Mellon University, Mellon College of Science and an infectious disease physician at David Weber, MD and Associates, both in Pittsburgh, Pennsylvania. Board certified in internal and emergency medicine, Dr. Adalja is a graduate of Carnegie Mellon University and a 2002 graduate of the American University of the Caribbean, St. Maarten, Kingdom of the Netherlands, Caribbean. He completed an internal/emergency medicine residency at Allegheny General Hospital and infectious diseases and critical care medicine fellowships at the University of Pittsburgh Medical Center. A fellow of the American College of Physicians, the American College of Emergency Physicians and the Infectious Diseases Society of America, Dr. Adalja is a member of the Society of Critical Care Medicine, the American Medical Association, the Pennsylvania Medical Society, the Butler County Medical Society, the Society for Academic Emergency Medicine, the HIV Medical Association, the Society of Critical Care Medicine, and the City of Pittsburgh HIV Commission. Dr. Adalja, faculty for this educational event, is on the speaker’s bureau/advisory committee for Merck, GlaxoSmithKline, Shionogi, is on the advisory committee for Emergent and has stock in Merck. All of the relevant financial relationships listed have been mitigated.